Stock SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Delayed NSE India S.E.
Other stock markets
 03:44:22 2024-06-10 am EDT 		5-day change 1st Jan Change
1,513 INR +0.39% Intraday chart for Sun Pharmaceutical Industries Ltd. +4.13% +20.13%
Jun. 07 Sun Pharmaceutical to Acquire 9.6% Stake in Genome Software Haystack Analytics MT
Jun. 06 Sun Pharmaceutical Industries Limited agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sun Pharmaceutical to Acquire 9.6% Stake in Genome Software Haystack Analytics
MT
Sun Pharmaceutical Industries Limited agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million.
CI
Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner of State Tax CT& GST -Territorial Range -Bhubaneswar
CI
Philogen, Inc. and Sun Pharmaceutical Industries Limited Announces Results of the Phase III PIVOTAL Trial of Nidlegy in Melanoma
CI
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
RE
Sun Pharma to Pursue M&A
CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical
MT
Taro Shareholders Approve Merger with Sun Pharma
AQ
Indian Equities Hit Intraday Record Highs on Thursday, Lifted by Easing Poll Worries, Strong Domestic Buying
MT
Sun Pharmaceutical Clocks Gains in Fiscal Q4 Consolidated Net Profit
MT
Transcript : Sun Pharmaceutical Industries Limited, Q4 2024 Earnings Call, May 22, 2024
Sun Pharmaceutical Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
India's Sun Pharma beats Q4 profit estimates
RE
Sun Pharmaceutical Industries Limited Recommends Final Dividend for the Financial Year 2023-2024
CI
Sun Pharmaceutical Industries Limited Appoints Dilip Shanghvi as Chairman of Board
CI
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger
AQ
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
RE
Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner Secunderabad, Telangana
CI
Sun Pharmaceutical Industries Limited entered into an agreement to acquire Valstar Investment S.a. for an enterprise value of $31 million.
CI
Sun Pharmaceutical Industries Limited Receives an Order Passed by Deputy Commissioner, DGSTO-5, Bengaluru, Karnataka
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUNPHARMA Stock
  4. News Sun Pharmaceutical Industries Ltd.